These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 37416222)

  • 1. Retracted: The Treatment Combining Antiangiogenesis with Chemoradiotherapy Impinges on the Peripheral Circulation Vascular Endothelial Cells and Therapeutic Effect in the Patients with Locally Advanced Nasopharyngeal Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9842547. PubMed ID: 38550099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retracted] Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway.
    Liu B; Cao G; Dong Z; Guo T
    Oncol Lett; 2024 Jun; 27(6):275. PubMed ID: 38690102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis.
    Liang ZG; Lin GX; Ye JX; Li Y; Li L; Qu S; Liang X; Zhu XD
    Asian Pac J Cancer Prev; 2018 May; 19(5):1397-1404. PubMed ID: 29802706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study.
    Xu T; Liu Y; Dou S; Li F; Guan X; Zhu G
    Oral Oncol; 2015 Sep; 51(9):875-9. PubMed ID: 26163437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cetuximab combined with IMRT and concurrent chemotherapy in treating locally advanced nasopharyngeal carcinoma.
    Yang P; Liu J; Yong H; Ma J; Gao X
    J BUON; 2021; 26(1):138-144. PubMed ID: 33721444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma.
    Feng HX; Guo SP; Li GR; Zhong WH; Chen L; Huang LR; Qin HY
    Med Oncol; 2014 Sep; 31(9):170. PubMed ID: 25119503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis.
    Wang L; Liu D; Wei D
    Comput Math Methods Med; 2022; 2022():5145549. PubMed ID: 36060662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9798503. PubMed ID: 37416222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy plus cetuximab or cisplatin in head and neck squamous cell carcinoma: an updated systematic review and meta-analysis of randomized controlled trials.
    Li Y; Yang C; Gan Y; Lu F; Qin Y
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):11-22. PubMed ID: 35986743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postoperative radiotherapy with cetuximab for head and neck squamous cell carcinoma patients at high risk of recurrence not eligible for cisplatin: A single-center experience and literature review].
    Marques O; Brenet E; Gaultier V; Marchand-Crety C
    Cancer Radiother; 2023 Feb; 27(1):17-22. PubMed ID: 35853823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck.
    Levy AR; Johnston KM; Sambrook J; Donato B; Penrod JR; Corral M; Chasen M
    Curr Med Res Opin; 2011 Dec; 27(12):2253-9. PubMed ID: 22017232
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.